ABSTRACT
Although granuloma annulare (GA) is a relatively common dermatologic condition, little is known about its epidemiology and pathogenesis. Additionally, there is conflicting evidence regarding its association with other diseases. In our retrospective study, we attempted to determine the number of cases of GA seen annually at a large academic center and clarify disease associations with GA. We utilized PennSeek, a tool developed by the Penn Medicine Data Analytics Center to search electronic medical records (EMRs), to identify all cases of GA seen at the University of Pennsylvania (Philadelphia, Pennsylvania) from 2008 to 2014. All biopsy-proven cases of GA from 2010 to 2014 were reviewed for medical comorbidities, medications, treatments, and outcomes. On average, the percentage of patients given a diagnosis of GA annually was 0.22%. There were 133 cases of biopsy-proven GA that were reviewed. The findings solidify our understanding of the epidemiology of GA and diseases that can be associated with GA.
Subject(s)
Biopsy , Granuloma Annulare/epidemiology , Female , Granuloma Annulare/diagnosis , Granuloma Annulare/therapy , Humans , Male , Pennsylvania , Retrospective Studies , Treatment OutcomeSubject(s)
Hyperpigmentation/pathology , Nevus, Blue/pathology , Skin Neoplasms/pathology , Back , Biopsy, Needle , Child , Delayed Diagnosis , Humans , Hyperpigmentation/diagnosis , Immunohistochemistry , Magnetic Resonance Imaging/methods , Male , Nevus, Blue/congenital , Nevus, Blue/surgery , Prognosis , Risk Assessment , Skin Neoplasms/congenital , Skin Neoplasms/surgery , Treatment OutcomeSubject(s)
Hyperpigmentation/pathology , Nevus, Blue/pathology , Skin Neoplasms/pathology , Back , Biopsy, Needle , Child , Follow-Up Studies , Humans , Hyperpigmentation/diagnosis , Immunohistochemistry , Magnetic Resonance Imaging/methods , Male , Nevus, Blue/congenital , Nevus, Blue/surgery , Risk Assessment , Skin Neoplasms/congenital , Skin Neoplasms/surgery , Treatment OutcomeSubject(s)
Blood Transfusion, Autologous/adverse effects , Immunotherapy/adverse effects , Lymphocyte Transfusion/adverse effects , Skin Diseases/etiology , T-Lymphocytes, Cytotoxic/transplantation , Adult , Aged , Antigens, CD19 , CD3 Complex/genetics , CD3 Complex/immunology , Cytokines/metabolism , Hematologic Neoplasms/therapy , Humans , Immunotherapy/methods , Male , Middle Aged , Neoplasms, Second Primary/diagnosis , Neoplasms, Second Primary/etiology , Neoplasms, Second Primary/immunology , Protein Domains , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/immunology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Skin Diseases/diagnosis , Skin Diseases/immunology , Skin Neoplasms/diagnosis , Skin Neoplasms/etiology , Skin Neoplasms/immunology , Syndrome , T-Lymphocytes, Cytotoxic/immunology , Tumor Necrosis Factor Receptor Superfamily, Member 9/genetics , Tumor Necrosis Factor Receptor Superfamily, Member 9/immunologySubject(s)
Continuity of Patient Care , Dermatology/organization & administration , Telemedicine/organization & administration , Dermatology/ethics , Electronic Health Records , Health Insurance Portability and Accountability Act , Health Services Needs and Demand , Humans , Internet , Privacy , Telemedicine/ethics , United StatesABSTRACT
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common heritable form of vascular dementia and it is caused by mutations in the NOTCH3 gene. The neurologic manifestations of CADASIL syndrome have been well characterized; however, here we report one of the first de novo cases of CADASIL-associated coronary artery disease. A 45-year-old woman with a history of CADASIL and remote tobacco use presented with unstable angina. She was found to have diffuse and irregular narrowing of the left anterior descending artery and a drug eluting stent was deployed. Months later, she developed two subsequent episodes of unstable angina, requiring stent placement in the distal left anterior descending artery and the right coronary artery. Though the neurologic manifestations of CADASIL have been well described, these patients may also be predisposed to developing premature coronary artery disease. Patients with CADASIL and their physicians should be aware of this possible association because these patients may not be identified as high risk by traditional cardiovascular risk estimators. These patients may benefit from more aggressive interventions to reduce cardiac risk.
ABSTRACT
Pemphigus vulgaris (PV) is a potentially fatal blistering disease caused by autoantibodies (autoAbs) against desmoglein 3 (Dsg3). Here, we clone anti-Dsg3 antibodies (Abs) from four PV patients and identify pathogenic VH1-46 autoAbs from all four patients. Unexpectedly, VH1-46 autoAbs had relatively few replacement mutations. We reverted antibody somatic mutations to their germline sequences to determine the requirement of mutations for autoreactivity. Three of five VH1-46 germline-reverted Abs maintain Dsg3 binding, compared with zero of five non-VH1-46 germline-reverted Abs. Site-directed mutagenesis of VH1-46 Abs demonstrates that acidic amino-acid residues introduced by somatic mutation or heavy chain VDJ recombination are necessary and sufficient for Dsg3 binding. Our data suggest that VH1-46 autoantibody gene usage is commonly found in PV because VH1-46 Abs require few to no mutations to acquire Dsg3 autoreactivity, which may favour their early selection. Common VH gene usage indicates common humoral immune responses, even among unrelated patients.
